Little Evidence Of Role Nutrition, Supplements Play In Cancer Patients – JNCI
This article was originally published in The Tan Sheet
Executive Summary
A review of several clinical trials evaluating diet modifications and/or supplement use by cancer patients "provides little evidence that specific interventions, or groups of interventions, have any effect, either beneficial or harmful," on the disease, according to a study published in the July 19 Journal of the National Cancer Institute
You may also be interested in...
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Commercialization Phase Brings New Challenges To Nanotech Industry
Increased industry/government collaboration is needed in the field of nanotechnology to move out of the research and development phase and into the commercialization phase, speakers told the President's Council of Advisors on Science and Technology during a June 25 meeting